Evidence Based Manager (HEOR)
UCB Inspired by patients. Driven by science.
Help us transform patients’ lives.
At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible.
With us, our talent makes the most of who they are, unlocking innovation and setting new standards for patients.
Everything we do starts with a simple question : How will this make a difference to the lives of people living with severe diseases?
And to find the answers, we connect globally with patients and their families living with the physical and social burdens of severe disease.
These connections give us new perspectives, drive our innovation, and offer a hope for a new generation of therapies that will help to transform lives.
To strengthen our UK Market Access Group, we are looking to fill the position of : Evidence Based Manager cross portfolio.
About the Role :
You will be responsible for :
Gaining national and local reimbursement and access for aligned UCB products.
Developing and implementing affiliate appropriate network meta-analyses, mixed treatment comparisons, systematic reviews, meta-
analyses and adjusted indirect comparisons.
Ensuring that PII / III trial programmes for New Medicines reflects UK clinical needs.
Identifying the need for Real World Evidence generation and subsequent development of proposals / protocols.
Leading, writing and coordinating the HTA content across selected UCB medicines.
Writing the clinical efficacy and safety sections of selected HTA submissions.
Day to day project management of selected HTA submissions.
Co-ordination of submission including Global inputs on strategy and content.
Gathering and developing external insights and evidence.
Increasing UCB profile in the field of Evidence based HTA and develop external partnerships with HTA and academic bodies.
Representing UCB across aligned products, with HTA bodies on all aspects of medical and safety section of the HTA submission.
Co-ordinating company responses to Commissioning Outcomes Framework (COF), Quality Outcomes Framework (QOF), Quality Standards and Guideline reviews.
You should have :
Degree in life sciences / EBM / Public Health / Epidemiology or equivalent.
Experience in writing clinical or scientific dossiers.
Previous experience of working on HTA or Clinical Guidelines or similar projects.
Knowledge of UK and Ireland Healthcare and HTA system.
Excellent written and data analysis skills.
Good knowledge of clinical documentation.
Ability to manage network analyses, mixed treatment comparisons, systematic reviews and meta-analyse.
Experience with data collection and utilisation of Real world evidence for purposes of Access and uptake ideally.
UCB The Facts
With more than 7500 employees in approximately 40 countries, we are a global biopharmaceutical company headquartered in Brussels, Belgium which invests more than 25% of revenue in cutting-
edge scientific research to meet unmet patient needs. A few other reasons that make UCB an amazing place to work :
Promising pipeline that includes several novel molecules and no major patent expiration in the next decade;
About 25% of 2016 revenue reinvested into Research & Development
2016 Key Financials : €4.2 billion global revenue Specialties : Neurology, Immunology